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1. Introduction 
Thyrotropin releasing-hormone (TRH), identified 
as the tripeptide pyroglutamyl-histidyl-proline 
amide, was isolated from hypothalamic tissue [ 1,2] 
and found to have both TSH and prolactin releasing 
activities [3]. Several reports described the genera- 
tion of antisera to the synthetic tripeptide after 
rendering it antigenic by coupling to a protein carrier, 
either through the proline residue [4] or through the 
histidine residue, using a symmetrical bifunctional 
coupling reagent in a one step reaction [5]. This 
paper describes the synthesis of an immunogenic 
protein conjugate of TRH using an asymmetrical 
bifunctional reagent in a two-step coupling procedure. 
Using antisera generated against his conjugate, a 
radioimmunoassay procedure for the peptide was 
developed, which permits the study of its distribu- 
tion in biological tissues. 
2. Materials and methods 
2.1. Preparation o f  TRH-BSA conjugate 
p-Diazonium phenylacetic acid was attached to 
synthetic TRH and the resulting azo-derivative (PAPA- 
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TRH) was coupled to bovine serum albumin (BSA). 
p-Aminophenylacetic acid (0.094 mmol) in 0.4 ml of 
cold 2 N HC1 was diazotized by sodium nitrite (0.1 
mmol in 50/~1 of water). Fifteen min later 0.094 
mmol TRH (Calbiochem USA) in 0.4 rnl of 3 N 
KHCO3 was added. The reaction mixture, which 
gradually turned pinkish-red, was stirred for 10 h at 
4°C. After acidification (pH 2.0) with 2 N HC1, the 
solution was extracted five times with ethylacetate, 
and the organic phase discarded; the aqueous phase 
was adjusted to pH 5.0 with KHCOa and lyophilized. 
The brownish product was extracted into absolute 
methanol, eaving insoluble white inorganic salts, and 
then precipitated by ether; the powder thus obtained 
was dissolved in absolute methanol and reprecipitated 
ether. Electrophoresis of the resultant brownish 
powder was carried out on Whatman No. 3 paper 
(pyridine acetate buffer, pH 6.5; 60 V/cm). Two 
components were detected with Pauli's reagent, one 
corresponding in mobility to unreacted TRH (30-50%, 
moving slightly towards the anode), the other 
(50-70%), moved towards the cathode. The latter 
component had a broad absorption peak in dimethyl- 
forinamide at 370-390 nm ()kma x = 380 nm; ~38o~DMF = 
4.8 X 103), consistent with its identification as an 
azo-histidyl derivative [6,7]. 
The PAPA-TRH derivative was attached to BSA 
(Crystalline grade, Miles Labs., Kankakee, Ill.), using 
1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide HC1 
at pH 5.0 [8]. Spectral analysis of the TRH-BSA 
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conjugate at 380 nm indicated that on the average 
24 residues of TRH were attached to each molecule 
of the carrier protein. 
2.2. Immunization 
Four mature male rabbits were injected subcutane- 
ously in several sites with an emulsion of TRH -BSA 
(0.25 rag/rabbit) in complete Freund's adjuvant 
supplemented with 1.6 units of a vaccine against 
Hemophilus pertussis (Pertussis Vaccine Fluid U.S.P., 
Eli Lilly & Co. Indianapolis). After two booster 
injections at intervals of two weeks, the rabbits were 
bled and the sera were examined for presence of 
antibodies. 
A conjugate of TRH and a multichain synthetic 
copolymer of L-lysine and DL-alanine: poly-DL-Ala- 
poly-L-lys, (tool. wt. = 142 500; Ala/Lys ratio = 20/I; 
[9] ) containing approximately 14% w/w of TRH was 
prepared by coupling the free carboxyl derivative of 
TRH (pGlu-His-Pro-OH) to the free amino groups 
of alanine, using N,N'-dicyclohexyl-carbodiimide in 
DMF as the coupling agent [ 10]. This preparation, 
when administered to rabbits, failed to produce anti 
TRH sera. 
2.3. Iodination and radioimmunoassay (RIA ) of TRH 
Labelling and RIA procedures for TRH were 
carried out as described previously for LH-Rt f  [11]. 
2.4. Dissection of various brain regions, and extraction 
o/ TRH 
Tissue fragments corresponding to different brain 
areas were excised according to de Groot [ 12]. TRH 
was extracted with 90% methanol, taken to dryness 
under a stream of air, and redissolved in 0.01 M 
phosphate-buffered saline (PBS), pH 6.9. 
3. Results 
3.1. Formation of antibodies to TRH 
Antibodies binding [12SI]TRH (~ 1 mCi//~g) 
appeared in the serum of the immunized rabbits two 
months after the first immunization. Three months 
later the serum of one immunized rabbit (No. 23) 
bound 50% of the labelled hormone (~ 50 pg per 
assay tube) at 1:20 000 final dilution; the correspond- 
ing titers of the sera from the other immunized 
rabbits ranged from 1 : 500 to 1 : 8000. 
3.2. Sensitivity and specificity of the antisera to TRH 
The sensitivity of the radioimmunoassay for TRH 
was found to be approx. 10 pg (fig.l). A reference 
preparation of rat hypothalamic extract with TSH 
releasing activity (NIAMD-Rat HE-RP-1) inhibited 
the binding of [12Sl]TRIt by the antiserum to TRH-  
BSA. The inhibition curve was parallel to that pro- 
duced by synthetic TRH (fig. 1). The extent to which 
the antiserum to TRH cross-reacted with various 
analogues of TRH or other peptide hormones is 
summarized in table 1. 
3.3. Distribution of TRH 
The distribution of TRH in various regions of the 
rat brain is summarized in table 2. 
4. Discussion 
Two approaches have recently been used to 
render TRH antigenic: (i) Conjugation of TRH to 
BSA through the carboxy-terminal of pGlu-His -  
Pro-OH (TRH-OH) [4]. A radioimmunoassay system 
based on antibodies generated against his antigen 
were able to detect only high concentrations (above 
100 pg) of TRH and cross-reacted xtensively with 
Hy pot halamic extract(equivalents) 
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Fig. 1. Inhibition of binding of [ ~ 2 s I I TRH to antiserum by 
unlabelled TRH or by rat hypothalamic extract (NIAMD-Rat 
HE-RP-1). Anti-TRH serum used at 1:20 000 dilution. 
296 
Volume 63, number 2 April 1976 FEBS LETTERS 
Table 1 
Specificity of anti-TRH serum 
Inhibition of 
No. Peptide [ 12~ I] TRH-binding (%) 
1 pGlu His-Pro-NH: (TRH) 100 
2 pGlu-His-Pro-OH (TRH-OH) 0.1 
3 pGlu-His-Trp-OH 0.01 
4 pGlu-His-OH 0.004 
5 His-Pro-NH~ < 0.001 
6 Pro-Leu-Gly-NH 2 (MIF) < 0.001 
7 Vasopressin < 0.001 
8 Oxytocin < 0.001 
9 LHRH < 0.001 
Peptides were tested in doses ranging from 10 ng to 100 ~g. Anti TRH was used 
at a final dilution of 1:20 000. Lysine-vasopressin a d oxytocin were the product 
of Sigma Chemical Co., St. Louis. LH-RH was kindly provided by Hoechst, AG, 
Frankfurt. Compounds No. 3 and 4 were gifts from Dr W. F. White. Compounds 
No. 2, 5 and 6 were synthetized in our laboratory. 
Table 2 
Distribution of TRH in rat brain 
Brain Region Wet weight (mg) TRH pg/mg 
Median eminence a 3.9 -+ 0.2 d 387.5 ± 21.2 
Preoptic area 16.7 +- 1.8 92.7 -+ 9.8 
Residual hypothalamus b 19.7 -+ 1.7 125.3 -+ 7.4 
Cerebral cortex 39.6 -+ 4.9 0.3 +- 0.02 
Posterior pituitary 1.1 +- 0.02 167.8 -+ 15 
Amygdala 25.6 +- 1.1 6.1 ± 1.9 
Hippocampus (dorsal) 45.4 ± 1.4 4.8 ± 0.4 
Olfactory tubercle + anterior 47.4 ± 2.0 21.8 +- 3.5 
olfactory nucleus 
Pineal gland c 5.0 ± 0.1 4.2 *- 0.1 
a The 'median eminence' includes parts of the medial basal hypothalamic nuclei. 
b Excluding the preoptic area, the median eminence, and the mammillary bodies. 
c Pools of five glands. 
d Mean and standard error of the mean for 6-12 determinations. 
the pG lu -H is -P ro -OMe and pGlu -H is -P ro -OH 
analogues of  TRH. Since TRH is rapidly inactivated 
in blood by conversion of  the amide to a carboxyl  
group [13],  results obtained with such antisera 
require careful interpretation. (ii) Coupling of  TRH 
to BSA [5] or to thyroglobul in [14,15] via the 
histidyl moiety by the bis-diazotized benzidine 
technique. Visser et al. [4] however have failed to 
produce antiserum to TRH by this method.  The 
reason for this may be that the one-step reaction 
util izing a symmetrical bifunctional reagent can result 
in dimerization and ol igomerization of  TRH. We, 
therefore, used an asymmetrical bifunctional reagent 
in a two-step coupling procedure. The antigen thus 
produced (PAPA-TRH) generated antisera with titers 
of  up to 1:20 000, and showed negligible cross 
reaction with four unrelated hypothalamic hormones 
(<0.001%) or with closely related ol igopeptides 
(table 1). Thus the TRH metabol ite (pG lu -H is -P ro -  
OH) showed little compet i t ion (0.1%) with intact 
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labelled TRH for antibodies binding sites when tested 
in a radioimmunoassay system (table 1). A rat hypo- 
thalamic extract (NIAMD-Rat HE-RP-1) with TSH- 
releasing activity displayed inhibition curves parallel 
to that of synthetic TRH (fig. 1). These characteristics, 
combined with high sensitivity (limit of detection 
approx. 10 pg), render this radioimmunoassay system 
capable of providing meaningful quantitative assess- 
ment of TRH in biological tissues. 
The highest concentration of TRH in rat brain was 
found in the median eminence (387 pg]mg); high 
concentrations were also found in the rest of the 
hypothalamus (125 pg/mg) and in the posterior 
pituitary. These results are in accord with those 
obtained by others [ 15-17] .  Lower concentrations 
were found in the preoptic area (93 pg/mg) and in 
the olfactory nucleus (22 pg/mg). In contrast o a 
recent report [18], only low TRtt levels (~ 4 pg/gland) 
were detected in the rat pineal gland. 
The high concentration of TRH in the rat hypo- 
thalamus is consistent with the biological role of this 
hormone in the regulation of TSH secretion from 
the pituitary. The extra-hypothalamic lo alization of 
TRH, however, may suggest further activities of this 
tripeptide, possibly exerted on neural tissue [19]. 
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